Sonepcizumab (Synonyms: LT 1009; Anti-Human S1P Recombinant Antibody) |
Katalog-Nr.GC69926 |
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P. Sonepcizumab has the potential for use in research on metastatic renal cell carcinoma (mRCC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1031360-18-5
Sample solution is provided at 25 µL, 10mM.
Review for Sonepcizumab
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Sonepcizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *